Cite
MLA Citation
K. Kent Chevli et al.. “Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.” Journal of urology, vol. 207, no. 1, 2022, pp. 61–69. http://access.bl.uk/ark:/81055/vdc_100146771890.0x000011